SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : WCAP - Winfield Capital: Insider buying -- Ignore unavailable to you. Want to Upgrade?


To: Rajiv who wrote (441)3/15/1999 11:53:00 PM
From: Jon Scott  Respond to of 1305
 
Today WCAP tomorrow...
GNII-more great earnings coming
Get in @ 1 3/8
siliconinvestor.com
GLOBENET SALES INCREASE 137% WITH RECORD EARNINGS
Business Wire
Oct 27 1998 4:57PM ET

Business Editors

DALLAS--(BUSINESS WIRE)--Oct. 27. 1998--GlobeNet International (OTC BB:GNII) reported a 137% increase in sales to $7,770,000 in the third quarter ended September 30, 1998 compared to sales of $3,279,000 in the same quarter last year, and earnings from continuing operations of $245,000, or $.02 per share, in the third quarter this year, compared to a loss from continuing operations of $226,000, or $.02 per share, for the same period last year.

Clinton Howard, CEO, attributed the earnings gain to rising sales in the Company's Royal BodyCare U.S., Canadian and International divisions of 1) Microhydrin(TM), a potent antioxidant, 2) Eye-Q(TM), a vegetarian DHA, which is essential to brain and eye development, but low in the American diet, and 3) FirstFood(TM), the exclusive microclustered form of Colostrum, a dietary supplement which supports the immune system.

GlobeNet, and its U.S. Royal BodyCare, U.S. division have leased a 119,000 sq. ft. building in Las Colinas, Irving, Texas, where its home office and warehouse will relocate on November 16, 1998.

The Company also reported that its attorneys are preparing a registration statement to be filed with the SEC to spin off its subsidiary, Great Xpectations (GX) with the issuance of one registered share of GX for each two shares of GlobeNet to shareholders of record on June 5, 1998. For accounting purposes, this spin off was effective at the close of business on June 30, 1998. The Company has classified the operations of GX as discontinued operations in its financial statements.

Royal BodyCare (RBC) sells technically advanced nutritional supplements, and Royal Botanica skin care products, for health and longevity, into 27 countries through 89,000 international distributors, shipped from Dallas and from branch RBC offices in Canada, Japan, Indonesia, Sweden and Switzerland.

Company products are also marketed worldwide over the Internet by those distributors who maintain their own web pages linked to the Company Web site, www.rbcglobenet.com.

--30--lm/da*

CONTACT: GlobeNet

Steve Brown, 972/401-0052

rbcglobenet.com

KEYWORD: TEXAS

ANTIOXIDANT SALES INCREASE GLOBENET REVENUE 122%
Business Wire
Jul 28 1998 1:44PM ET
Business Editors

DALLAS--(BUSINESS WIRE)--July 28, 1998--GlobeNet(R) International (OTC BB:GNII) reported a 122% increase in sales to $6,641,000, in the second quarter ended June 30, 1998 compared to sales of $2,997,000 in the same quarter last year, and earnings from continuing operations of $161,000 in the second quarter this year, compared to a loss from continuing operations of $237,000 for the same period last year.

The company attributed the earnings gain to: 1) continued rising sales of the company's antioxidant, Mycrohydrin(tm), in its U.S. and Canadian Royal BodyCare divisions, and 2) the addition of 42,000 direct marketing distributors in the past year, primarily in the U.S., but also in Canada, Japan, Indonesia, and the Scandinavian countries.

GlobeNet president, Clinton H. Howard explained, "Microhydrin is an entirely new development in the growing science of nutritional supplementation. It provides additional electrons needed by the body, and missing in our modern diets which are high in acidic, oxidized foods and beverages. Microhydrin makes any food you eat similar in certain aspects to raw, organically grown fruits and vegetables, and improves drinking water so that it is less acidic and no longer oxidized."

Mr. Howard also announced that Royal BodyCare of Switzerland will open its first office and warehouse for Europe on August 21 in Zurich.

GlobeNet, a Dallas based company, has leased a 119,000 sq ft building in Las Colinas, Irving, Texas, where its home office and warehouse will relocate in September.

At its annual shareholders' meeting this month the current members of the Board of Directors were reelected, and the board was increased with the addition of Frank Franasiak, M.D. a Virginia physician who is Board Certified in Obstetrics and Gynecology.

The Company also reported that its attorneys are preparing a registration statement to be filed with the SEC to spin off its subsidiary, Great Expectations (GX) with the issuance of one registered share of GX for each two shares of GlobeNet (GNII) to shareholders of record on June 5, 1998. The company has classified the operations of GX as discontinued operations in its financial statements. The Company reported a loss from discontinued operations of $103,000 for the second quarter of 1998, compared with income from discontinued operations of $38,000 for the same period in 1997.

GlobeNet (OTC BB:GNII), through its Royal BodyCare divisions, directly markets worldwide 200 high quality nutritional supplements, featuring Microhydrin and Microclusters(R), an additive designed to increase intestinal absorption and bioavailabilty of all nutrients. GlobeNet also markets telecommunication services, and web pages which enable its 85,000 distributors in 21 countries to advertise and sell RBC products via their individual home pages, as well as through the company web site, www.rbcglobenet.com.

--30--DJ/da*

CONTACT: GlobeNet

Steve Brown, 972/401-0052

E-mail:sbrown@rbcglobenet.com

KEYWORD: TEXAS




To: Rajiv who wrote (441)3/16/1999 12:21:00 AM
From: Tom Hua  Respond to of 1305
 
Rajiv, WCAP owns Series B which, as you pointed out, is converted to 2/3 of common stock. An update of the table is forthcoming tomorrow.

Regards,

Tom



To: Rajiv who wrote (441)3/16/1999 12:28:00 AM
From: Tom Hua  Read Replies (2) | Respond to of 1305
 
Winfield Capital has purchased about 1.2 million shares of preferred stock of Juno which are convertible, currently on a one for one basis, into shares of common stock of Juno.

Rajiv, WCAP issued the same statement with its holdings in ROWE, Worldgate, and Mpath. We now know that conversion is not on a 1-to-1 basis. The conversion factor of WCAP's preferred shares is 0.39 for ROWE common, 0.667 for Worldgate, and 0.611 for Mpath. WCAP paid $1.43/share for certain Series preferred stock in JUNO only last month. I suspect the conversion factor will be around 0.2.

Regards,

Tom



To: Rajiv who wrote (441)4/16/1999 9:25:00 PM
From: Tom Hua  Read Replies (3) | Respond to of 1305
 
Can we get an update of the famous Hua tables

Rajiv, a month late and many shares short (pun intended), here's the
update. As you know very well, WCAP purchased preferred stocks which
are converted to common stocks at a certain conversion factor.

Here are WCAP's holdings:

----------------------------------------------------------------------
Symbol/ Preferred Conversion Common Price Value
Company Shares Factor Shares per share $MM
----------------------------------------------------------------------

COOL 1,464,000 16 23.4

ROWE 440,200 0.349 153,676 36 5.5

WGAT 140,000 0.667 93,380 44 4.1

MPATH 227,273 0.610 138,637 40 (E) 5.5

JUNO 1,178,304 0.180 212,095 40 (E) 8.5

----------------------------------------------------------------------

Total Value: 47.0
(E): Estimated

There are 5.72 MM WCAP shares. The value per share is $8.2.

The rest of WCAP's old loan business and other small investments is
valued at about $2. It is no coincidence that WCAP was changing hands
at ~$10 just weeks ago.

Fact is anybody can own the equivalence of a WCAP share by buying the
same stocks in the open market and pay about 8 bucks. Not only that
one can sell the securities anytime while WCAP is restricted from
selling until the lock-up periods end. Prices can fluctuate
significantly in the interim. Because of the uncertainty, WCAP records
70% of the unrealized gain/loss on its balance sheet.

I may be untrendy, but I take no pleasure in overpaying. Since some
people like to overpay, I took the opportunity to borrow shares from
my broker and sold them the shares.

Regards,

Tom